Over the past year several new drug-eluting stents (DES) stents have been released and SYNTAX trial data proved DES compare as well as coronary artery bypass graft surgery (CABG) in patient outcomes. DES vs. CABG
Metal stents are foreign objects that can irritate vessels and cause stent thrombosis, prevent vessel remodeling, prevent future surgical interventions, can fatique and suffer strut fractures, and impair CT or MR imaging. For these reasons several stent manufacturers are working on biodegradeble stents that do not leave behind any hardware.
September 17, 2009 - The Senate Finance Committee reduced the imaging utilization assumption rate from 90 percent to 65 percent, in essence cutting the originally proposed utilization increase by nearly two-thirds.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
September 17, 2009 - Lantheus Medical Imaging Inc. today announced the initiation of a Phase 1 clinical study to assess the safety, dosimetry and tolerability of LMI1195, a novel F-18 small molecule tracer for imaging cardiac neuronal function, in healthy subjects, undergoing positron emission tomography (PET) imaging.
The polymer coating on drug-eluting stents (DES) used to carry the antiproliferative drugs cause an increased risk of stent thrombosis, months or even years after a stent is implanted. This has led stent manufacturers to look for or ways to eliminate the vessel irritating polymers for better biocompatibility usually associated with bare metal stents (BMS).
September 16, 2009 – Guided Delivery Systems Inc. (GDS) announced the first successful percutaneous implantation of the GDS Accucinch System for mitral valve repair.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
September 16, 2009 - Medrad will host a breakfast symposium, “Complete Thrombus Management During Rapid STEMI Intervention,” during TCT 2009, starting at 6:30 a.m. Thursday, Sept. 24, in Moscone Center, room 130.
September 16, 2009 – Texas Cardiac Arrhythmia Institute at St. David’s Medical Center in Austin, Texas plans to create a worldwide electrophysiology (EP) telecardiology network for live consultations with other EP labs anywhere in the world using the Odyssey Network offered by Stereotaxis.
September 15, 2009 – EVEREST registry clinical results of the MitraClip therapy for patients with mitral regurgitation (MR) will be a big topic of discussion at the Transcatheter Cardiovascular Therapeutics (TCT) Conference Sept. 21-25 in San Francisco.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
September 16, 2009 – MemorialCare Heart and Vascular Institute at Long Beach Memorial Medical Center (LBMMC) in Long Beach, Calif., said it implanted a new, heart attack detection device in two heart attack survivors yesterday.
September 16, 2009 – Hansen Medical Inc. today said it received FDA clearance for its next generation Sensei X Robotic Catheter System and it introduced the Artisan Extend Control Catheter. The company also plans to introduce the Lynx Robotic Ablation Catheter, a small, flexible irrigated ablation catheter, for customers in Europe this fall.
September 15, 2009 – Tryton Medical Inc. said today its Tryton Side Branch Stent has been used in 250 procedures to treat atherosclerotic lesions at bifurcations in patients with heart disease.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
September 15, 2009 – Bracco is hosting a breakfast symposium at TCT 2009, “Evidence-Based Selection of Contrast Media in Interventional Cardiology,” for interventional cardiologists, cardiologists, nurses and technologists, informing them of the latest clinical evidence for contrast-induced nephropathy, including risk factors and best treatment options.
September 15, 2009 – Spacelabs Healthcare today announced the U.S. launch of Sentinel, a sophisticated cardiology information management systems (CIMS), which facilitates analysis and reporting while also improving efficiency and eliminating errors.
September 15, 2009 – Fluid monitoring with OptiVol Fluid Status Monitoring is a more accurate predictor of worsening heart failure compared to daily weight monitoring in heart failure patients with implantable devices, according to results released yesterday from the FAST (Fluid Accumulation Status Trial) clinical trial.